Jacques Simiand

3.2k total citations · 1 hit paper
32 papers, 2.7k citations indexed

About

Jacques Simiand is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, Jacques Simiand has authored 32 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 5 papers in Social Psychology. Recurrent topics in Jacques Simiand's work include Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Jacques Simiand is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Jacques Simiand collaborates with scholars based in France, Italy and Mexico. Jacques Simiand's co-authors include Philippe Soubrié, P.E. Keane, Michel Morre, Guy Griebel, B. Scatton, Jean‐Pierre Maffrand, Georges Chapouthier, Patrice Venault, Robert H. Dodd and Claudine Serradeil‐Le Gal and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Jacques Simiand

32 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks

1986 468 citations Patrice Venault, Georges Chapouthier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques Simiand France	23	1.3k	713	633	603	440	32	2.7k
Ian A. Paul United States	38	1.9k 1.5×	1.1k 1.5×	653 1.0×	654 1.1×	429 1.0×	91	4.0k
A.M. Domeney United Kingdom	31	2.2k 1.8×	1.3k 1.8×	782 1.2×	747 1.2×	504 1.1×	63	3.6k
J. Engel Sweden	31	1.8k 1.4×	849 1.2×	384 0.6×	341 0.6×	362 0.8×	86	2.9k
Luciano Angelucci Italy	33	1.7k 1.4×	931 1.3×	700 1.1×	1.2k 2.0×	483 1.1×	96	3.6k
Alessandro Tagliamonte Italy	29	1.5k 1.2×	700 1.0×	363 0.6×	301 0.5×	250 0.6×	52	2.8k
Paul Moser France	28	1.8k 1.4×	1.2k 1.7×	438 0.7×	522 0.9×	506 1.1×	71	3.5k
Barrett R. Cooper United States	35	2.5k 2.0×	1.4k 2.0×	399 0.6×	357 0.6×	388 0.9×	73	4.0k
Paola Devoto Italy	33	1.9k 1.5×	863 1.2×	266 0.4×	323 0.5×	592 1.3×	88	3.0k
John H. Kehne United States	33	1.9k 1.5×	903 1.3×	351 0.6×	386 0.6×	533 1.2×	68	3.2k
Neil M. Richtand United States	31	1.0k 0.8×	779 1.1×	468 0.7×	473 0.8×	197 0.4×	59	2.8k

Countries citing papers authored by Jacques Simiand

Since Specialization

Citations

This map shows the geographic impact of Jacques Simiand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Simiand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Simiand more than expected).

Fields of papers citing papers by Jacques Simiand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Simiand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Simiand. The network helps show where Jacques Simiand may publish in the future.

Co-authorship network of co-authors of Jacques Simiand

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Simiand. A scholar is included among the top collaborators of Jacques Simiand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Simiand. Jacques Simiand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Griebel, Guy, Jacques Simiand, Jeanne Stemmelin, Claudine Serradeil‐Le Gal, & R. Steinberg. (2003). The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders. PubMed. 2(3). 191–200. 65 indexed citations

Griebel, Guy, Ghislaine Perrault, Jacques Simiand, et al.. (2003). SL651498, a GABA_AReceptor Agonist with Subtype‐Selective Efficacy, as a Potential Treatment for Generalized Anxiety Disorder and Muscle Spasms. CNS Drug Reviews. 9(1). 3–20. 66 indexed citations

Griebel, Guy, Jacques Simiand, Claudine Serradeil‐Le Gal, et al.. (2002). Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proceedings of the National Academy of Sciences. 99(9). 6370–6375. 381 indexed citations

Steinberg, R., Richard Alonso, L. Rouquier, et al.. (2002). SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}-4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin 1 Receptor: II. Neurochemical and Behavioral Characterization. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1180–1188. 30 indexed citations

Gal, Claudine Serradeil‐Le, Jean Wagnon, Jacques Simiand, et al.. (2002). Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 300(3). 1122–1130. 180 indexed citations

Griebel, Guy, Jacques Simiand, R. Steinberg, et al.. (2002). 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders. Journal of Pharmacology and Experimental Therapeutics. 301(1). 333–345. 197 indexed citations

Griebel, Guy, et al.. (2001). Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery. Neuroscience & Biobehavioral Reviews. 25(7-8). 619–626. 22 indexed citations

Perrier, Lionel, et al.. (2000). Disposition of Irbesartan, an Angiotensin II AT1-Receptor Antagonist, in Mice, Rats, Rabbits, and Macaques. Drug Metabolism and Disposition. 28(1). 79–88. 30 indexed citations

Alonso, Richard, M. Arnone, Robert Boigegrain, et al.. (1999). SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization. Journal of Pharmacology and Experimental Therapeutics. 289(2). 752–761. 25 indexed citations

10.

Simiand, Jacques, et al.. (1999). Disposition of tiludronate (Skelid) in animals. Xenobiotica. 29(10). 1017–1031. 14 indexed citations

11.

Simiand, Jacques, et al.. (1998). SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.. PubMed. 9(2). 179–81. 224 indexed citations

12.

Poncelet, Martine, et al.. (1995). Antidepressant-like effects of SR 57227A, a 5-HT3 receptor agonist, in rodents. Journal of Neural Transmission. 102(2). 83–90. 27 indexed citations

13.

Rinaldi‐Carmona, Murielle, Monsif Bouaboula, Christian Congy, et al.. (1993). Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist. European Journal of Pharmacology Molecular Pharmacology. 246(1). 73–80. 27 indexed citations

14.

Rinaldi-Carmona, M, Christian Congy, Jacques Simiand, et al.. (1993). Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain.. Molecular Pharmacology. 43(1). 84–89. 27 indexed citations

15.

Simiand, Jacques, P.E. Keane, Xavier Langlois, et al.. (1992). Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical β-adrenoceptors. European Journal of Pharmacology. 219(2). 193–201. 41 indexed citations

16.

Rinaldi-Carmona, M, Christian Congy, Vincent Santucci, et al.. (1992). Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 262(2). 759–768. 100 indexed citations

17.

Simiand, Jacques, P.E. Keane, Kathleen Bizière, & Philippe Soubrié. (1989). Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants.. PubMed. 297. 272–85. 17 indexed citations

18.

Keane, P.E., Jacques Simiand, Michel Morre, & Kathleen Bizière. (1988). Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.. Journal of Pharmacology and Experimental Therapeutics. 245(2). 692–698. 20 indexed citations

19.

Venault, Patrice, Georges Chapouthier, Jacques Simiand, Robert H. Dodd, & Jean Rossier. (1987). Enhancement of performance by methyl β-carboline-3-carboxylate, in learning and memory tasks. Brain Research Bulletin. 19(3). 365–370. 30 indexed citations

20.

Santucci, Vincent, et al.. (1985). EEG effects of IV infusion of pentylenetetrazol in rats: A model for screening and classifying antiepileptic compounds. Psychopharmacology. 87(3). 337–343. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact